Have a personal or library account? Click to login
Borderline personality disorder: what do we know about the possibilities of pharmacotherapy? Literature review and case study Cover

Borderline personality disorder: what do we know about the possibilities of pharmacotherapy? Literature review and case study

Biuletyn Głównej Biblioteki Lekarskiej
Volume 57 (2024): Issue 382 (June 2024)
By: Stanisław Chrapusta,  Adrian Ochocki and  Magdalena Flaga-Łuczkiewicz  
Open Access
|Jun 2024

Authors

Stanisław Chrapusta

Warszawski Uniwersytet Medyczny, Studenckie Koło Naukowe Psychiatrii Ambulatoryjnej przy NZOZ Centrum Terapii DIALOG, Warszawa

Adrian Ochocki

Warszawski Uniwersytet Medyczny, Studenckie Koło Naukowe Psychiatrii Ambulatoryjnej przy NZOZ Centrum Terapii DIALOG, Warszawa

Magdalena Flaga-Łuczkiewicz

NZOZ Centrum Terapii DIALOG, Warszawa
DOI: https://doi.org/10.2478/bgbl-2024-0004 | Journal eISSN: 2956-6851 | Journal ISSN: 0373-174X
Journal RSS Feed
Language: English
Page range: 51 - 60
Published on: Jun 16, 2024
Published by: The Medical Library named after S. Konopka in Warsaw
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
borderline personality disorder,
BPD,
pharmacotherapy,
oxcarbazepine,
OXC
Related subjects:
Medicine,
Biomedical engineering

© 2024 Stanisław Chrapusta, Adrian Ochocki, Magdalena Flaga-Łuczkiewicz, published by The Medical Library named after S. Konopka in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Previous articleVolume 57 (2024): Issue 382 (June 2024)Next article